Understanding HER2+ breast cancer in diverse populations
Her2 status of breast cancer in diverse populations: improving genetic prediction and understanding molecular correlates
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA AT DAVIS · NIH-11078209
This study is looking at how genetics and other factors affect HER2-positive breast cancer in Hispanic/Latina and Asian American women, with the goal of better understanding cancer risks and treatment results, and it invites patients to share their genetic samples and health information to help improve care for everyone.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA AT DAVIS (nih funded) |
| Locations | 1 site (DAVIS, UNITED STATES) |
| Trial ID | NIH-11078209 on ClinicalTrials.gov |
What this research studies
This research investigates the genetic and molecular factors associated with HER2-positive breast cancer, particularly in Hispanic/Latina and Asian American women. It aims to improve the prediction of cancer risk and treatment outcomes by studying how these factors differ across various racial and ethnic groups. By analyzing genetic data and tumor characteristics, the research seeks to address disparities in breast cancer treatment and outcomes. Patients may be involved in providing genetic samples and health information to help advance this important work.
Who could benefit from this research
Good fit: Ideal candidates for this research include women from Hispanic/Latina and Asian American backgrounds who have been diagnosed with breast cancer.
Not a fit: Patients who do not have breast cancer or do not belong to the targeted racial/ethnic groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate predictions of breast cancer risk and tailored treatments for diverse populations.
How similar studies have performed: Previous studies have shown promising results in understanding HER2+ breast cancer in diverse populations, indicating that this research builds on established findings.
Where this research is happening
DAVIS, UNITED STATES
- UNIVERSITY OF CALIFORNIA AT DAVIS — DAVIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FEJERMAN, LAURA — UNIVERSITY OF CALIFORNIA AT DAVIS
- Study coordinator: FEJERMAN, LAURA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.